Brief: Pure Biologics FY 2021 Net Loss At 11.8 Mln Zlotys
31/03/2022 16:15
March 31 (Reuters) - Pure Biologics SA PUR1.WA :
* FY 2021 NET LOSS OF 11.8 MILLION ZLOTYS VERSUS LOSS OF
11.8
MILLION ZLOTYS YEAR AGO
* FY 2021 OPERATING REVENUE 18.0 MILLION ZLOTYS VERSUS 16.7
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEMZFb6Ra
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects